When we think about drug discovery, the words fast and efficient don’t usually come to mind - but a Singapore-based biotech startup is challenging that reality.
Nanyang Biologics is harnessing the power of AI and an extensive library of tropical bioactives to accelerate how we discover new treatments, not just for humans, but for animals too.
So how are they doing it?
On the Right Business, Hongbin Jeong speaks to Giang Nyugen, Chief Technology Officer of Nanyang Biologics (NYB), to find out more.

The Big Story: Who is Mojtaba Khamenei, Iran’s new Supreme Leader and how might his rule change the US‑Iran war?
13:46

Wealth Tracker: Why gold & silver are the new first investment for Gen Z and Millennials
17:55

What's Trending: Would you live with your parents to splurge on luxury? And is this energy habit causing you to fight at home?
17:40